This TRAIL-dependent cytokine and chemokine production was observed in different carcinogenic cell types, and an accumulation of tumor-supportive immune cells in the cancer microenvironment has been described in an endogenous TRAIL/TRAIL-R-mediated chemokine (C-C motif) ligand 2 (CCL2) secretion [23]. The gene discussed is CCL2; the disease is cancer.